“drug-development” Archives

Entry Author Date Location
After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes? 10/18/16 Boston
Alnylam Scraps RNAi Drug After Safety Problems, Shares Plunge 10/05/16 Boston
Gates Grant Helps Sirenas Extend Hunt for Drugs From Sea Organisms 10/03/16 San Diego
Retrophin Drug Licensed by Shkreli Shows Positive Phase 2 Results 09/07/16 San Diego
Governments Pay for Research, Jobs in San Antonio Tech and Science 08/18/16 Texas
Pharma’s Productivity Problem: Finding More Blockbuster Drugs 08/17/16 San Diego
Dauntless Takes Flight with New Business Model for Starting Biotechs 07/21/16 San Diego
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
Evoke Pharma’s Stock Sinks on Stomach Drug’s Phase 3 Failure 07/18/16 San Diego
Xbiotech Responds to ESMO, Other Critics of Phase 3 Cancer Data 07/15/16 Texas
Tissue Analyzer 3Scan Builds Out Machine Learning With $14M Series B 07/11/16 San Francisco
After Three Deaths, FDA Halts Juno’s Leading CAR-T Trial 07/07/16 Seattle
Early Stage San Antonio Drug Trial Firm START Opens Taiwan Outpost 05/20/16 Texas
West Coast Biotech Roundup: Acadia, Medivation, Verily, and More 05/06/16 San Diego
Pfizer Invests in Wave, Inks Metabolic-Focused Drug Development Deal 05/05/16 Boston
AstraZeneca Spinout Entasis Snags $50M For Anti-Infective Treatments 04/04/16 Boston
When Data Meets Genomics, Where Does Computing Power Come From? 04/01/16 Texas
Blueprint, Roche Ink Milestone Deal for Cancer Immunotherapy 03/15/16 Boston
GenSpera, Pursuing Partners, Tests Toxin-Based Drug in Brain Cancer 02/03/16 Texas
Misfit Vets Out to Debug Science Experiments With Elemental Machines 02/03/16 Boston
TwoXAR Grabs $3.4M for Algorithm-Based Drug Discovery 11/18/15 San Francisco
Advancing Drugs at Roche, Sophiris, Coherus, and Other Bio News 11/13/15 San Diego
To Curb Brain Damage, Astrocyte Pharmaceuticals Energizes Cells 10/19/15 Texas
Aimmune Prices Upsized $160M IPO, Climbs Higher in Debut 08/06/15 San Francisco
With $550M Fund, Deerfield Management Tackles Early Stage Biotech 07/28/15 New York
East Coast Biotech Roundup: Celgene, Chiasma, Cerulean, & More 07/17/15 Boston
Orphan Drug Maker Chiasma Raises $101.8M in IPO 07/16/15 Boston
FDA Grants Blueprint Go-Ahead for Kinase Inhibitor Trials 07/13/15 Boston
Biogen R&D Chief Doug Williams Leaves to Run New Cancer Startup 07/10/15 Boston
Epizyme Extends Celgene Cancer Deal for $10M Upfront 07/09/15 Boston
Page 1 of 15 next page »